Analyst Ratings for NGM Biopharmaceuticals (NGM)

NGM Rating Summary

  |   Expand Research on NGM
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3 / 10   Percentile Rank: 26%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/12/2024 Raymond James Steven Seedhouse Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 1.53
(1.54)		 0.65% Details
2/28/2024 B.Riley
» Updated 2/28/2024		 Yuan Zhi Downgrade Neutral
(Buy)		 1.55
(3.50)		 1.63
(1.54)		 -5.52% Details